Day: May 13, 2026

us corporate news

OSR Holdings, Inc. Q1 2026 Financial Report: Business Combination, Subsidiary Overview, and Key Financial Results

Minichart

May 13, 2026

OSR Holdings, Inc. Reports Q1 2026 Results: Key Financial an...

Continue Reading 0

us corporate news

Canton Strategic Holdings, Inc. Quarterly Report (Form 10-Q) Highlights Financials, Digital Asset Strategy, and Market Risks

Minichart

May 13, 2026

Canton Strategic Holdings, Inc. – Q1 2026 Financial Report A...

Continue Reading 0

us corporate news

Table Trac, Inc. 2026 Q1 Financial Results: Revenue, Profit, and Key Financial Statements (10-Q Report)

Minichart

May 13, 2026

Table Trac, Inc. Q1 2026 Financial Report Detailed Analysis ...

Continue Reading 0

us corporate news

Veru Inc. 2026 Q2 Financial Report: Key Risks, Results, and Clinical Trial Updates

Minichart

May 13, 2026

Veru Inc. Q2 2026 Financial Report: Key Highlights and Inves...

Continue Reading 0

us corporate news

Hennessy Capital Investment Corp. VII Q1 2026 10-Q Report – Financial Statements, Business Combination Updates, and SEC Filings

Minichart

May 13, 2026

Hennessy Capital Investment Corp. VII Q1 2026 Results: Key H...

Continue Reading 0

us corporate news

Protalix BioTherapeutics Reports Q1 2026 Results: $18.3M Net Income, $25M Milestone From Chiesi, and Strong Guidance for 2026

Minichart

May 13, 2026

Protalix BioTherapeutics Q1 2026 Financial and Business Upda...

Continue Reading 0

us corporate news

Veru Reports Q2 2026 Results and Progress on Phase 2b PLATEAU Trial for Enobosarm Plus Semaglutide in Obesity Treatment

Minichart

May 13, 2026

Veru Inc. Reports Fiscal Q2 2026 Results & Provides Clinical...

Continue Reading 0

us corporate news

BeyondSpring Reports Q1 2026 Financial Results: Plinabulin Pipeline Progress and SEED Therapeutics Clinical Update

Minichart

May 13, 2026

BeyondSpring Inc. Announces Q1 2026 Financial Results: Key H...

Continue Reading 0

us corporate news

Avalo Therapeutics Reports Positive Phase 2 Results for Abdakibart in Hidradenitis Suppurativa and Raises $431M to Fund Phase 3 Trial

Minichart

May 13, 2026

Avalo Therapeutics Reports Positive Q1 2026 Results and Majo...

Continue Reading 0

us corporate news

Ralliant Corporation Files Form 8-K Announcing Key Company Information and NYSE Listing

Minichart

May 13, 2026

Ralliant Corporation Announces \$100 Million Accelerated Sha...

Continue Reading 0